Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (8): 771-775.DOI: 10.3969/j.issn.1673-8640.2023.08.012
Previous Articles Next Articles
FU Limei, YANG Dan(), XU Jin, ZHU Haiyan, ZHU Fenhua
Received:
2022-07-11
Revised:
2023-04-30
Online:
2023-08-30
Published:
2023-10-30
CLC Number:
FU Limei, YANG Dan, XU Jin, ZHU Haiyan, ZHU Fenhua. Clinical significance of whole blood trace elements and serum vitamin levels in 6 common skin diseases in children[J]. Laboratory Medicine, 2023, 38(8): 771-775.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.08.012
组别 | 例数 | 铜/(μmol/L) | 锌/(μmol/L) | 铁/(mmol/L) |
---|---|---|---|---|
皮肤病组 | 301 | 15.17(14.54,16.10) | 73.03(72.61,73.59)* | 7.60(7.60,7.70)* |
斑秃组 | 50 | 15.16(14.50,16.08) | 73.23(72.88,73.86)* | 7.60(7.60,7.70)* |
特应性皮炎组 | 51 | 15.20(14.50,16.08) | 72.85(72.30,73.10)* | 7.70(7.60,7.70) |
甲疾患组 | 50 | 15.15(14.43,16.10) | 72.93(72.55,73.21)* | 7.70(7.70,7.70) |
剥落性角质松懈症组 | 50 | 15.80(14.58,16.20) | 73.13(72.83,73.63)** | 7.70(7.70,7.70) |
白色糠疹组 | 50 | 15.11(14.74,16.01) | 72.98(72.48,73.57)* | 7.60(7.60,7.60)* |
白斑病组 | 50 | 15.10(14.52,16.02) | 73.04(72.84,73.73)* | 7.60(7.60,7.60)* |
正常对照组 | 52 | 15.60(14.15,16.95) | 80.95(79.65,82.57) | 7.80(7.70,7.80) |
组别 | 例数 | 铜/(μmol/L) | 锌/(μmol/L) | 铁/(mmol/L) |
---|---|---|---|---|
皮肤病组 | 301 | 15.17(14.54,16.10) | 73.03(72.61,73.59)* | 7.60(7.60,7.70)* |
斑秃组 | 50 | 15.16(14.50,16.08) | 73.23(72.88,73.86)* | 7.60(7.60,7.70)* |
特应性皮炎组 | 51 | 15.20(14.50,16.08) | 72.85(72.30,73.10)* | 7.70(7.60,7.70) |
甲疾患组 | 50 | 15.15(14.43,16.10) | 72.93(72.55,73.21)* | 7.70(7.70,7.70) |
剥落性角质松懈症组 | 50 | 15.80(14.58,16.20) | 73.13(72.83,73.63)** | 7.70(7.70,7.70) |
白色糠疹组 | 50 | 15.11(14.74,16.01) | 72.98(72.48,73.57)* | 7.60(7.60,7.60)* |
白斑病组 | 50 | 15.10(14.52,16.02) | 73.04(72.84,73.73)* | 7.60(7.60,7.60)* |
正常对照组 | 52 | 15.60(14.15,16.95) | 80.95(79.65,82.57) | 7.80(7.70,7.80) |
组别 | 例数 | Vit A/(μmol/L) | Vit B1/(nmol/L) | Vit B2/(μg/L) |
---|---|---|---|---|
皮肤病组 | 301 | 0.65(0.58,0.76)* | 55.72±4.65* | 210.60(203.28,216.45)** |
斑秃组 | 50 | 0.51(0.50,0.70)** | 56.18±5.12 | 208.62(198.21,217.31)* |
特应性皮炎组 | 51 | 0.68(0.61,0.78) | 56.35±4.06 | 213.58(198.65,218.50)* |
甲疾患组 | 50 | 0.65(0.58,0.73)* | 55.09±4.99* | 210.43(204.87,216.02)* |
剥落性角质松懈症组 | 50 | 0.67(0.62,0.78) | 56.27±4.46 | 209.10(203.44,215.90)** |
白色糠疹组 | 50 | 0.68(0.58,0.80) | 55.03±4.58* | 209.73(204.05,214.39)** |
白斑病组 | 50 | 0.65(0.60,0.76) | 55.39±4.64* | 211.42(205.04,218.81)* |
正常对照组 | 52 | 0.75(0.68,0.82) | 57.44±4.88 | 214.39(208.53,220.52) |
组别 | Vit B6/(μmol/L) | Vit C/(μmol/L) | 25(OH)D3/(nmol/L) | |
皮肤病组 | 17.10(15.21,18.76)** | 38.23(36.52,39.84)* | 29.63(27.04,33.11)* | |
斑秃组 | 17.45(15.17,19.42)* | 38.30(36.19,40.00) | 28.42(26.15,31.34)** | |
特应性皮炎组 | 16.33(15.02,18.51)** | 37.56(35.65,39.22)* | 30.22(28.10,34.33)* | |
甲疾患组 | 16.36(15.01,18.76)** | 38.28(36.43,40.22) | 29.68(27.16,33.73)* | |
剥落性角质松懈症组 | 17.67(15.37,19.04)* | 38.28(36.89,39.29) | 28.40(26.86,34.54)* | |
白色糠疹组 | 17.03(15.31,18.21)** | 37.75(36.70,39.29)* | 30.31(27.29,33.47)* | |
白斑病组 | 17.11(14.63,19.52) | 39.10(36.88,40.34) | 30.17(26.79,33.11)* | |
正常对照组 | 18.76(18.00,19.98) | 38.96(37.49,40.69) | 31.06(29.57,32.56) |
组别 | 例数 | Vit A/(μmol/L) | Vit B1/(nmol/L) | Vit B2/(μg/L) |
---|---|---|---|---|
皮肤病组 | 301 | 0.65(0.58,0.76)* | 55.72±4.65* | 210.60(203.28,216.45)** |
斑秃组 | 50 | 0.51(0.50,0.70)** | 56.18±5.12 | 208.62(198.21,217.31)* |
特应性皮炎组 | 51 | 0.68(0.61,0.78) | 56.35±4.06 | 213.58(198.65,218.50)* |
甲疾患组 | 50 | 0.65(0.58,0.73)* | 55.09±4.99* | 210.43(204.87,216.02)* |
剥落性角质松懈症组 | 50 | 0.67(0.62,0.78) | 56.27±4.46 | 209.10(203.44,215.90)** |
白色糠疹组 | 50 | 0.68(0.58,0.80) | 55.03±4.58* | 209.73(204.05,214.39)** |
白斑病组 | 50 | 0.65(0.60,0.76) | 55.39±4.64* | 211.42(205.04,218.81)* |
正常对照组 | 52 | 0.75(0.68,0.82) | 57.44±4.88 | 214.39(208.53,220.52) |
组别 | Vit B6/(μmol/L) | Vit C/(μmol/L) | 25(OH)D3/(nmol/L) | |
皮肤病组 | 17.10(15.21,18.76)** | 38.23(36.52,39.84)* | 29.63(27.04,33.11)* | |
斑秃组 | 17.45(15.17,19.42)* | 38.30(36.19,40.00) | 28.42(26.15,31.34)** | |
特应性皮炎组 | 16.33(15.02,18.51)** | 37.56(35.65,39.22)* | 30.22(28.10,34.33)* | |
甲疾患组 | 16.36(15.01,18.76)** | 38.28(36.43,40.22) | 29.68(27.16,33.73)* | |
剥落性角质松懈症组 | 17.67(15.37,19.04)* | 38.28(36.89,39.29) | 28.40(26.86,34.54)* | |
白色糠疹组 | 17.03(15.31,18.21)** | 37.75(36.70,39.29)* | 30.31(27.29,33.47)* | |
白斑病组 | 17.11(14.63,19.52) | 39.10(36.88,40.34) | 30.17(26.79,33.11)* | |
正常对照组 | 18.76(18.00,19.98) | 38.96(37.49,40.69) | 31.06(29.57,32.56) |
[1] |
DIBAISE M, TARLETON S M. Hair,nails,and skin:differentiating cutaneous manifestations of micronutrient deficiency[J]. Nutr Clin Pract, 2019, 34(4):490-503.
DOI URL |
[2] |
OGAWA Y, KINOSHITA M, SHIMADA S, et al. Zinc and skin disorders[J]. Nutrients, 2018, 10(2):199.
DOI URL |
[3] | 马琳. 儿童皮肤病学[M]. 北京: 人民卫生出版社, 2014. |
[4] |
CALDWELL C C, SAIKALY S K, DELLAVALLE R P, et al. Prevalence of pediatric alopecia areata among 572 617 dermatology patients[J]. J Am Acad Dermatol, 2017, 77(5):980-981.
DOI URL |
[5] | 姚志荣. 儿童皮肤病学发展现状与未来[J]. 中华皮肤科杂志, 2017, 50(11):777-783. |
[6] | 尹晓慧. 新编儿童皮肤病学[M]. 长春: 吉林科学技术出版社, 2019. |
[7] | 管会苓. 剥脱性角质松解症与免疫功能的关系探讨[J]. 中国实用乡村医生杂志, 2016, 23(4):57-58. |
[8] | 郭琳雯, 张丽, 蒋滟蕲, 等. 973例儿童和成人白癫风患者流行病学及临床特征分析[J]. 现代预防医学, 2019, 46(24):4518-4522. |
[9] |
MOHAN G C, SILVERBERG J I. Association of vitiligo and alopecia areata with atopic dermatitis:a systematic review and meta-analysis[J]. JAMA Dermatol, 2015, 151(5):522-528.
DOI URL |
[10] |
WESSELS I, MAYWALD M, RINK L. Zinc as a gatekeeper of immune function[J]. Nutrients, 2017, 9(12):1286.
DOI URL |
[11] |
OGAWA Y, KAWAMURA T, SHIMADA S. Zinc and skin biology[J]. Arch Biochem Biophys, 2016, 611:113-119.
DOI PMID |
[12] | 管会苓. 血清微量元素检测在皮肤病中的临床应用观察[J]. 世界最新医学信息文摘, 2021, 21(92):479-480. |
[13] | 何秀玲, 陈礼娇, 李金密, 等. 重庆地区斑秃患者血微量元素的测定与分析[J]. 国际检验医学杂志, 2018, 39(10):1263-1266. |
[14] | GLUTSCH V, HAMM H, GOEBELER M. Zinc and skin:an update[J]. J Dtsch Dermatol Ges, 2019, 17(6):589-596. |
[15] |
CHASAPIS C T, NTOUPA P A, SPILIOPOULOU C A, et al. Recent aspects of the effects of zinc on human health[J]. Arch Toxicol, 2020, 94(5):1443-1460.
DOI PMID |
[16] | SAID H M, ROSS A. Riboflavin. Modern nutrition in health and disease[M]. 11th ed. Baltimore: Lippincott Williams & Wilkins, 2014. |
[17] |
VANBUREN C A, EVERTS H B. Vitamin A in skin and hair:an update[J]. Nutrients, 2022, 14(14):2952.
DOI URL |
[18] |
MAAROUF M, VAUGHN A R, SHI V Y. Topical micronutrients in atopic dermatitis-an evidence-based review[J]. Dermatol Ther, 2018, 31(5):e12659.
DOI URL |
[19] |
NOSEWICZ J, SPACCARELLI N, ROBERTS K M, et al. The epidemiology,impact,and diagnosis of micronutrient nutritional dermatoses part 1:zinc,selenium,copper,vitamin A,and vitamin C[J]. J Am Acad Dermatol, 2022, 86(2):267-278.
DOI URL |
[20] | SIVARANJANI N, RAO S V, RAJEEV G. Role of reactive oxygen species and antioxidants in atopic dermatitis[J]. J Clin Diagn Res, 2013, 7(12):2683-2685. |
[21] |
WANG K, JIANG H, LI W, et al. Role of vitamin C in skin diseases[J]. Front Physiol, 2018, 9:819.
DOI PMID |
[22] |
UMAR M, SASTRY K S, AL ALI F, et al. Vitamin D and the pathophysiology of inflammatory skin diseases[J]. Skin Pharmacol Physiol, 2018, 31(2):74-86.
DOI URL |
[23] | 崔文娟, 万明顺, 岳美娜. 儿童白色糠疹与血微量元素、25-羟基维生素D的相关性[J]. 临床医学研究与实践, 2019, 4(30):124-125. |
[24] |
SAINI K, MYSORE V. Role of vitamin D in hair loss:a short review[J]. J Cosmet Dermatol, 2021, 20(11):3407-3414.
DOI URL |
[25] |
GAMONAL S B L, GAMONAL A C C, MARQUES N C V, et al. 25-Hydroxyvitamin D as a biomarker of vitamin D status in plaque psoriasis and other dermatological diseases:a cross-sectional study[J]. Sao Paulo Med J, 2022, 141(2):131-137.
DOI URL |
[26] |
GOPINATH S, SUTARIA N, BORDEAUX Z A, et al. Reduced serum pyridoxine and 25-hydroxyvitamin D levels in adults with chronic pruritic dermatoses[J]. Arch Dermatol Res, 2023, 315(6):1771-1776.
DOI |
[27] | BERGQVIST C, EZZEDINE K. Vitamin D and the skin:what should a dermatologist know?[J]. G Ital Dermatol Venereol, 2019, 154(6):669-680. |
[1] | WANG Huiying, TANG Yu, DONG Lili, WANG Jing. Role of Mycoplasma pneumoniae RNA determination in diagnosis and efficacy monitoring of pneumonia in children [J]. Laboratory Medicine, 2023, 38(9): 865-869. |
[2] | SHI Yingying, PAN Fen, SUN Yan, WANG Chun, JIANG Jie, YU Fangyuan, ZHANG Tiandong, QIN Huihong, ZHANG Hong. Nested multiple polymerase chain reaction in rapid diagnosis of meningitis/encephalitis in children [J]. Laboratory Medicine, 2023, 38(8): 766-770. |
[3] | ZHANG Xin, MA Lijuan. Role of cardiac markers in children [J]. Laboratory Medicine, 2023, 38(6): 505-509. |
[4] | YANG Qiong, XU Fen, LIN Yahui. Clinical application of cardiac troponin determination in pediatric cardiac involvement related diseases [J]. Laboratory Medicine, 2023, 38(6): 510-517. |
[5] | LI Li, SUN Haiyan, LI Yuanrui, DOU Min, TANG Wen, JIANG Limin, SHEN Lisong. Changes and clinical roles of perioperative NT-proBNP and PCT in children with congenital heart disease [J]. Laboratory Medicine, 2023, 38(6): 524-531. |
[6] | WANG Yaling, HUANG Yunli, TIAN Mi, WANG Shunlan, XIAO Li. Relationship between EOS%,CCR3,eotaxin and disease severity in children with acute bronchopneumonia [J]. Laboratory Medicine, 2023, 38(3): 230-234. |
[7] | WU Jinying, FANG Yulian, WANG Wei, HOU Mengzhu, WANG Lu, ZHAO Yu. Clinical characteristics and epidemiological of enterovirus infection in children with acute diarrhea in Tianjin [J]. Laboratory Medicine, 2023, 38(3): 267-271. |
[8] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[9] | HU Shaohua, CHEN Li, ZHAO Meng, MA Zhan, ZHANG Hong. Epidemiological characteristic analysis of Mycoplasma pneumoniae infection in children in Shanghai [J]. Laboratory Medicine, 2023, 38(1): 14-17. |
[10] | WEI Rui, YUAN Xu, TIAN Xuewen, LU Yanjun. Clinical and laboratory characteristics of human metapneumovirus infection children in a Grade A Class 3 hospital in Wuhan [J]. Laboratory Medicine, 2023, 38(1): 18-22. |
[11] | LU Lijuan, XU Jin. Thoughts on whether adenovirus is the cause of the hepatitis of unknown etiology among children recently [J]. Laboratory Medicine, 2022, 37(8): 705-709. |
[12] | AO Jiajia, ZHANG Junfeng, NIE Wenjian, YE Qing. Relationship of fasting C-peptide with nonalcoholic fatty liver disease in children with obesity [J]. Laboratory Medicine, 2022, 37(7): 618-622. |
[13] | LIU Yang, GENG Kunjing, LI Hongjiang, SHI Haoxi, CHEN Sisi. Relationship of 25(OH)D3 and liver inflammatory stage with the efficacy of antiviral therapy [J]. Laboratory Medicine, 2022, 37(7): 628-631. |
[14] | PAN Fen, PAN Yuxuan, SHI Yingying, YU Fangyuan, ZHANG Hong. UroQuick rapid urine culture technique for urinary tract infection in children [J]. Laboratory Medicine, 2022, 37(7): 652-656. |
[15] | ZHAO Ying, XU Jin. Role of fecal calprotectin in children's intestinal diseases [J]. Laboratory Medicine, 2022, 37(5): 429-432. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||